company background image
TBD logo

Emerald Health Therapeutics DB:TBD Stock Report

Last Price

€0.016

Market Cap

€5.4m

7D

4.6%

1Y

-70.9%

Updated

13 Nov, 2022

Data

Company Financials

Emerald Health Therapeutics, Inc.

DB:TBD Stock Report

Market Cap: €5.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

TBD Stock Overview

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada.

TBD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Emerald Health Therapeutics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Emerald Health Therapeutics
Historical stock prices
Current Share PriceCA$0.016
52 Week HighCA$0.071
52 Week LowCA$0.014
Beta0.63
1 Month Change4.58%
3 Month Change-36.00%
1 Year Change-70.91%
3 Year Change-95.93%
5 Year Change-98.97%
Change since IPO-95.95%

Recent News & Updates

Recent updates

Shareholder Returns

TBDDE PharmaceuticalsDE Market
7D4.6%-2.6%-0.4%
1Y-70.9%-27.1%5.0%

Return vs Industry: TBD underperformed the German Pharmaceuticals industry which returned -13.3% over the past year.

Return vs Market: TBD underperformed the German Market which returned -21.8% over the past year.

Price Volatility

Is TBD's price volatile compared to industry and market?
TBD volatility
TBD Average Weekly Movement45.8%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.3%
10% least volatile stocks in DE Market2.5%

Stable Share Price: TBD's share price has been volatile over the past 3 months.

Volatility Over Time: TBD's weekly volatility has increased from 39% to 46% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a111n/ahttps://emeraldhealth.ca

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015.

Emerald Health Therapeutics, Inc. Fundamentals Summary

How do Emerald Health Therapeutics's earnings and revenue compare to its market cap?
TBD fundamental statistics
Market cap€5.44m
Earnings (TTM)-€20.52m
Revenue (TTM)€5.19m

1.0x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TBD income statement (TTM)
RevenueCA$7.13m
Cost of RevenueCA$12.67m
Gross Profit-CA$5.54m
Other ExpensesCA$22.64m
Earnings-CA$28.18m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.13
Gross Margin-77.71%
Net Profit Margin-395.33%
Debt/Equity Ratio0%

How did TBD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.